Improving care for first episode psychosis in Chile

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the treatment of individuals experiencing First Episode Psychosis (FEP) in Chile by implementing evidence-based practices in community mental health clinics. It focuses on the integration of a coordinated specialty care model within the existing public health framework to ensure that patients receive timely and effective interventions. The study will compare the outcomes of a new intervention program against usual FEP services to assess improvements in patient care and symptom management. By leveraging Chile's unique position as a low-and-middle-income country with a policy framework for FEP services, the study seeks to address gaps in mental health care delivery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals who have FEP (First Episode Psychosis)
* Individuals who are receiving services at a participating outpatient mental health clinic.
* Individuals who meet ICT-10 criteria for a diagnosis of schizophrenia, schizophreniform, schizoaffective disorder, delusional disorder, brief psychotic disorder, or psychosis not otherwise specified.
* Individuals who have the capacity to provide fully informed consent. (For those under age 18, capacity to provide assent plus informed consent of parent/guardian.)
* Individuals who are able to participate in research assessments in Spanish

Exclusion Criteria:

* Individuals who have a non-psychiatric medical condition that impairs functioning.
* Individuals who have a psychosis due solely to another medical condition.
* Individuals who have a psychosis due to a developmental disability.

Where it's running

• CESAM San Joaquín
  Santiago, Chile Recruiting

Study contacts

• Principal investigator: Ruben Alvarado, MD PhD — University of Chile
• Study coordinator: Ruben Alvarado, MD PhD
• Email: ralvarado@med.uchile.cl
• Phone: 562 2 903 0000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• State Representation in Early Psychosis 2

  This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.

  Recruiting at 2 sites University of Minnesota · Minneapolis, Minnesota and 1 other locations · NCT07834203

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Combined brain stimulation and yoga for improving cognition in psychosis

  This study tests whether active brain stimulation plus yoga can improve thinking skills and daily function in adults with psychosis.

  Recruiting The Hong Kong Polytechnic University · Hung Hom, Kowloon · NCT07747181

• See if an early-detection program reduces time to treatment for first-episode psychosis

  We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.

  Recruiting at 2 sites Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Copenhagen, Denmark and 1 other locations · NCT07716969

• Cerebellar imaging markers to predict antipsychotic response in first-episode psychosis

  This will test whether cerebellar brain scans can predict how people with first-episode psychosis respond to 12 weeks of treatment with risperidone or aripiprazole.

  Recruiting Phase 4 Northwell Health · Glen Oaks, New York · NCT07483294

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.